Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo

Cancer Letters

Volumn 227, Issue 1, 2005, Pages 83-93

  Miyata, Shiro ^a   Uchinokura, Shunro ^a   Fukushima, Tsuyoshi ^a   Hamasuna, Ryouichi ^a   Itoh, Hiroshi ^a   Akiyama, Yutaka ^a   Nakano, Shinichi ^a   Wakisaka, Shinichiro ^a   Kataoka, Hiroaki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Glioblastoma; HAI 1; Hepatocyte growth factor (HGF); HGF activator; Protease inhibitor

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 1; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOGENICITY; CONTROLLED STUDY; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C;

EID: 22744454871     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.010     Document Type: Article

References (29)

1. T. Moriyama, H. Kataoka, H. Tsubouchi, and M. Koono Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro, FEBS Lett. 372 1995 78 82
2. T. Moriyama, H. Kataoka, K. Seguchi, H. Tsubouchi, and M. Koono Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells Int J Cancer 66 1996 678 685
3. E.M. Rosen, J. Laterra, A. Joseph, L. Jin, A. Fuchs, D. Way, M. Witte, M. Weinand, and I.D. Goldberg Scatter factor expression and regulation in human glial tumors Int J Cancer 67 1996 248 255
4. S. Koochekpour, M. Jeffers, S. Rulong, G. Taylor, E. Klineberg, E.A. Hudson, J.H. Resau, and G.F. Vande Woude Met and hepatocyte growth factor/scatter factor expression in human gliomas, Cancer Res. 57 1997 5391 5398
5. J. Laterra, M. Nam, E. Rosen, J.S. Rao, K. Lamszus, I.D. Goldberg, and P. Johnston Scatter factor/hepatecyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo Lab Invest. 76 1997 565 577
6. R. Abounader, S. Ranganathan, B. Lal, K. Fielding, A. Book, H. Dietz, P. Burger, and J. Laterra Reversion of human glioblastoma malignancy by U1 small nuclear RNA/Ribozyme targeting of scatter factor/hepatecyte growth factor and c-met expression J Natl Cancer Inst 91 1999 1548 1556
7. H. Kataoka, S. Miyata, S. Uchinokura, and H. Itoh Roles of hepatocyte growh factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor Cancer Metast Rev 22 2003 223 236
8. K. Miyazawa, T. Shimomura, A. Kitamura, J. Kondo, Y. Morimoto, and N. Kitamura Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor J Biol Chem 268 1993 10024 10028
9. S.L. Lee, R.B. Dickson, and C.Y. Lin Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease, J Biol Chem 275 2000 36720 36725
10. T. Shimomura, K. Denda, A. Kitamura, T. Kawaguchi, M. Kito, and J. Kondo Hepatocyte growth factor activator inhibitor, a novel Kunitz type serine protease inhibitor, J Biol Chem 272 1997 6370 6376
11. T. Kawaguchi, L. Qin, T. Shimomura, J. Kondo, K. Matsumoto, K. Denda, and N. Kitamura Purification and cloning of Hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inihibitor, J Biol Chem 272 1997 27558 27564
12. H. Kataoka, T. Shimomura, T. Kawaguchi, R. Hamasuna, H. Itoh, N. Kitamura, K. Miyazawa, and M. Koono Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment J Biol Chem 275 2000 40453 40462
13. C.Y. Lin, J. Anders, M. Johnson, and R.B. Dickson Purification characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk J Biol Chem 274 1999 18237 18242
14. M.D. Oberst, C.A. Williams, R.B. Dickson, M.D. Johnson, and C.Y. Lin The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor, J Biol Chem 278 2003 26773 26779
15. R. Hamasuna, H. Kataoka, and J. Y Meng H. Itoh, T. Moriyama, S. Wakisaka, M. Koono, Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells, Int J Cancer 93 2001 339 345
16. C.S. Gondi, S.S. Lakka, N. Yanamandra, K. Siddique, D.H. Dinh, and W.C. Olivero M Gujrati, J.S Rao, Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis, Oncogene 22 2003 5967 5975
17. A. Giese, and M. Westphal Glioma invasion in the central nervous system Neurosurgery 39 1996 235 252
18. H. Kataoka, H. Itoh, and M. Koono Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration Pathol Int 52 2000 89 102
19. N. Devoogdt, G.H. Ghassabeh, J. Zhang, L. Brys, P.D. Baetselier, and H. Revets Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells Proc Natl Acad Sci USA 100 2003 5778 5782
20. J.Y. Meng, H. Kataoka, H. Itoh, and M. Koono Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo Int J Cancer 92 2001 31 39
21. S.Y. Ko, S.C. Lin, K.W. Chang, Y.K. Wong, C.J. Liu, C.W. Chi, and T.Y. Liu Increased expression of amylid precursor protein in oral squamous cell carcinoma Int J Cancer 111 2004 727 732
22. C.S. von Koch, H. Zheng, H. Chen, M. Trumbauer, G. Thinakaran, L.H.T. van der Ploeg, D.L. Price, and S.S. Sisodia Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice Neurol. Aging 18 1997 661 669
23. K.J. Mitchell, K.I. Pinson, O.G. Kelly, J. Brennan, J. Zupicich, P. Scherz, P.A. Leighton, L.V. Goodrich, X. Lu, B.J. Avery, P. Tate, K. Dill, E. Pangilinan, P. Wakenight, M. Tessier-Lavigne, and W. Skarnes Functional analysis of secreted and transmembrane proteins critical to mouse development Nat Genet 28 2001 241 249
24. M.D. Oberst, M.D. Johnson, R.B. Dickson, C-Y. Lin, B. Singh, M. Stewart, A. Williams, A. al-Nafussi, J.F. Smyth, H. Gabra, and G.C. Sellar Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumor clinicopathological parameters Clin Cancer Res 8 2002 1101 1107
25. J.Y. Kang, M. Dolled-Filhart, I.T. Ocal, B. Singh, C-Y. Lin, R.B. Dickson, D.L. Rimm, and R.L. Camp Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer, Cancer Res 63 2003 1101 1105
26. C. Parr, G. Watkins, R.E. Mansel, and W.G. Jiang The hepatocyte growth factor regulatory factors in human breast cancer Clin Cancer Res 10 2004 202 211
27. K. Nagaike, K. Kohama, S. Uchiyama, H. Tanaka, K. Chijiiwa, H. Itoh, and H. Kataoka Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front Cancer Sci 95 2004 728 735
28. H. Kataoka, H. Uchino, K. Denda, N. Kitamura, H. Itoh, H. Tsubouchi, K. Nabeshima, and M. Koono Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa Cancer Lett. 128 1998 219 227
29. H. Kataoka, R. Hamasuna, H. Itoh, N. Kitamura, and M. Koono Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma Cancer Res 60 2000 6148 6159